11 results
8-K
EX-3.1
WGS
GeneDx Holdings Corp - Ordinary Shares
28 Apr 23
Material Modifications to Rights of Security Holders
9:06am
8-K
EX-3.1
WGS
GeneDx Holdings Corp - Ordinary Shares
17 Apr 23
Departure of Directors or Certain Officers
5:11pm
8-K
EX-3.1
WGS
GeneDx Holdings Corp - Ordinary Shares
9 Jan 23
Sema4 Announces Name Change to GeneDx and Provides Preliminary 2022 Financial Results and 2023 Guidance
4:00pm
8-K
EX-3.2
WGS
GeneDx Holdings Corp - Ordinary Shares
9 Jan 23
Sema4 Announces Name Change to GeneDx and Provides Preliminary 2022 Financial Results and 2023 Guidance
4:00pm
8-K
EX-3.1
WGS
GeneDx Holdings Corp - Ordinary Shares
2 May 22
Katherine Stueland, former President and CEO of GeneDx, joins Sema4 as CEO and will serve on Board of Directors
8:30am
8-K
EX-3.2
57gk w2jycl
28 Jul 21
Sema4 Closes Transaction with CM Life Sciences, Debuts as Publicly Traded AI-driven Genomic & Clinical Data Platform Company
5:24pm
8-K
EX-3.1
f9uv2
28 Jul 21
Sema4 Closes Transaction with CM Life Sciences, Debuts as Publicly Traded AI-driven Genomic & Clinical Data Platform Company
5:24pm
8-K
EX-3.1
ziek mgtywdf
4 Sep 20
Entry into a Material Definitive Agreement
5:06pm
S-1/A
EX-3.1
a4k7hax5v o53
24 Aug 20
IPO registration (amended)
10:25am
S-1/A
EX-3.2
tsv8ormp5sc
24 Aug 20
IPO registration (amended)
10:25am
S-1/A
EX-3.3
4cfhakt9ctzzxhrtb
24 Aug 20
IPO registration (amended)
10:25am
- Prev
- 1
- Next